Sun Jin Sym

3.3k total citations
102 papers, 1.7k citations indexed

About

Sun Jin Sym is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Sun Jin Sym has authored 102 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Oncology, 48 papers in Pulmonary and Respiratory Medicine and 23 papers in Surgery. Recurrent topics in Sun Jin Sym's work include Colorectal Cancer Treatments and Studies (25 papers), Gastric Cancer Management and Outcomes (24 papers) and Lung Cancer Treatments and Mutations (18 papers). Sun Jin Sym is often cited by papers focused on Colorectal Cancer Treatments and Studies (25 papers), Gastric Cancer Management and Outcomes (24 papers) and Lung Cancer Treatments and Mutations (18 papers). Sun Jin Sym collaborates with scholars based in South Korea, United States and United Kingdom. Sun Jin Sym's co-authors include Dong Bok Shin, Eun Kyung Cho, Jinny Park, Hee Kyung Ahn, Junshik Hong, Sung Sook Lee, Jin‐Hee Ahn, Sung‐Bae Kim, Woo Kun Kim and Young Saing Kim and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Sun Jin Sym

95 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sun Jin Sym South Korea	25	809	750	336	289	230	102	1.7k
Minkyu Jung South Korea	26	1.2k 1.5×	886 1.2×	454 1.4×	256 0.9×	473 2.1×	140	2.1k
Dusan Kotasek Australia	28	1.2k 1.4×	542 0.7×	183 0.5×	371 1.3×	448 1.9×	104	2.3k
Thierry Alcindor Canada	18	1.3k 1.6×	1.3k 1.8×	455 1.4×	290 1.0×	422 1.8×	85	2.4k
Jung Yong Hong South Korea	25	1.2k 1.5×	605 0.8×	407 1.2×	607 2.1×	509 2.2×	194	2.3k
Javier Gállego Spain	21	875 1.1×	485 0.6×	408 1.2×	150 0.5×	184 0.8×	131	1.4k
Thibault Voron France	18	1.3k 1.5×	687 0.9×	821 2.4×	189 0.7×	377 1.6×	74	2.4k
Maria Giulia Zampino Italy	23	1.7k 2.1×	808 1.1×	625 1.9×	198 0.7×	318 1.4×	95	2.5k
Cristina Grávalos Spain	23	1.7k 2.1×	960 1.3×	426 1.3×	300 1.0×	514 2.2×	81	2.3k
Dae Young Zang South Korea	27	1.1k 1.4×	1.3k 1.7×	593 1.8×	206 0.7×	558 2.4×	184	2.6k
Blair Marshall United States	9	630 0.8×	514 0.7×	222 0.7×	103 0.4×	795 3.5×	10	1.7k

Countries citing papers authored by Sun Jin Sym

Since Specialization

Citations

This map shows the geographic impact of Sun Jin Sym's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sun Jin Sym with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sun Jin Sym more than expected).

Fields of papers citing papers by Sun Jin Sym

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sun Jin Sym. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sun Jin Sym. The network helps show where Sun Jin Sym may publish in the future.

Co-authorship network of co-authors of Sun Jin Sym

This figure shows the co-authorship network connecting the top 25 collaborators of Sun Jin Sym. A scholar is included among the top collaborators of Sun Jin Sym based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sun Jin Sym. Sun Jin Sym is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kim, Hyung‐Don, Sun Jin Sym, Hong Jae Chon, et al.. (2025). Multicenter single-arm phase II trial of lenvatinib in patients with advanced hepatocellular carcinoma after progression on first-line atezolizumab plus bevacizumab. Journal of Hepatology. 84(2). 308–315. 3 indexed citations

Jeong, Hyehyun, Changhoon Yoo, Il Hwan Kim, et al.. (2025). Gemcitabine and Cisplatin Plus Polymeric Micellar Paclitaxel and Survival in Advanced Biliary Tract Cancer. JAMA Network Open. 8(10). e2534560–e2534560.

Lee, Keun Wook, Devalingam Mahalingam, Byoung Yong Shim, et al.. (2025). DKN-01 and tislelizumab as second-line therapy in DKK1-high gastroesophageal adenocarcinoma: DisTinGuish trial part B. Nature Communications. 16(1). 6393–6393.

Cheon, Chunhoo, Hyun Woo Lee, Sun Jin Sym, & Seong‐Gyu Ko. (2024). Safety of the Herbal Medicine SH003 in Patients With Solid Cancer: A Multi-Center, Single-Arm, Open-Label, Dose-Escalation Phase I Study. Integrative Cancer Therapies. 23. 1573608587–1573608587. 5 indexed citations

Go, Se‐Il, Sang‐Cheol Lee, Woo Kyun Bae, et al.. (2021). Modified FOLFIRINOX versus S-1 as second-line chemotherapy in gemcitabine-failed metastatic pancreatic cancer patients: A randomised controlled trial (MPACA-3). European Journal of Cancer. 157. 21–30. 17 indexed citations

Kim, Young Saing, Inkeun Park, Hee Kyung Ahn, et al.. (2021). Predictive Roles of HER2 Gene Amplification and Neutrophil-to-Lymphocyte Ratio on Survival in HER2-Positive Advanced Gastric Cancer Treated With Trastuzumab-Based Chemotherapy. American Journal of Clinical Oncology. 44(6). 232–238. 5 indexed citations

Boku, Narikazu, M.-H. Ryu, D-Y. Oh, et al.. (2020). LBA7_PR Nivolumab plus chemotherapy versus chemotherapy alone in patients with previously untreated advanced or recurrent gastric/gastroesophageal junction (G/GEJ) cancer: ATTRACTION-4 (ONO-4538-37) study. Annals of Oncology. 31. S1192–S1192. 80 indexed citations

Sym, Sun Jin, et al.. (2019). Concordance Assessment and Satisfaction of Medical Professionals for the Artificial Intelligence Watson. 7(2). 112–118. 1 indexed citations

Chung, Dong Hae, Na Rae Kim, Hyun Yee Cho, et al.. (2019). Intraoperative Frozen Cytology of Central Nervous System Neoplasms: An Ancillary Tool for Frozen Diagnosis. Journal of Pathology and Translational Medicine. 53(2). 104–111. 8 indexed citations

10.

Kim, Sangwoo, Yeon Kyung Lee, Jeong Hee Hong, et al.. (2018). Mutual Destruction of Deep Lung Tumor Tissues by Nanodrug‐Conjugated Stealth Mesenchymal Stem Cells. Advanced Science. 5(5). 1700860–1700860. 29 indexed citations

11.

Kim, Young Saing, Eun Kyung Cho, Junshik Hong, et al.. (2015). Randomized Phase II Study of Pemetrexed Versus Gefitinib in Previously Treated Patients with Advanced Non-small Cell Lung Cancer. Cancer Research and Treatment. 48(1). 80–87. 13 indexed citations

12.

Kim, Young Saing, Sun Jin Sym, Inkeun Park, et al.. (2015). Low-dose capecitabine plus trastuzumab as first-line treatment in patients 75 years of age or older with HER2-positive advanced gastric cancer: a pilot study. Cancer Chemotherapy and Pharmacology. 76(6). 1267–1272. 6 indexed citations

13.

Hong, Junshik, Hee Kyung Ahn, Sun Jin Sym, et al.. (2015). Pre-treatment blood inflammatory markers as predictors of systemic infection during induction chemotherapy: results of an exploratory study in patients with acute myeloid leukemia. Supportive Care in Cancer. 24(1). 187–194. 6 indexed citations

14.

Hong, Junshik, Song Mi Moon, Hee Kyung Ahn, et al.. (2013). Comparison of Characteristics of Bacterial Bloodstream Infection between Adult Patients with Allogeneic and Autologous Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 19(6). 994–999. 26 indexed citations

15.

Hong, Junshik, Hee Kyung Ahn, Sun Jin Sym, et al.. (2013). Prognostic Role of Serum Lactate Dehydrogenase Beyond Initial Diagnosis: A Retrospective Analysis of Patients with Diffuse Large B Cell Lymphoma. Acta Haematologica. 130(4). 305–311. 17 indexed citations

16.

Kim, Young Saing, Sun Jin Sym, Se Hoon Park, et al.. (2013). A randomized phase II study of weekly docetaxel/cisplatin versus weekly docetaxel/oxaliplatin as first-line therapy for patients with advanced gastric cancer. Cancer Chemotherapy and Pharmacology. 73(1). 163–169. 18 indexed citations

17.

Park, Yae Min, Jinny Park, Sun Jin Sym, et al.. (2009). Prolonged Extreme Thrombocytosis in a Postsplenectomy Patient with Hereditary Spherocytosis. The Korean Journal of Hematology. 44(4). 298–298. 3 indexed citations

18.

Sym, Sun Jin, Heung Moon Chang, Min‐Hee Ryu, et al.. (2009). Neoadjuvant Docetaxel, Capecitabine and Cisplatin (DXP) in Patients with Unresectable Locally Advanced or Metastatic Gastric Cancer. Annals of Surgical Oncology. 17(4). 1024–1032. 47 indexed citations

19.

Lee, Sung Sook, Jin‐Hee Ahn, Min Kyoung Kim, et al.. (2007). Brain metastases in breast cancer: prognostic factors and management. Breast Cancer Research and Treatment. 111(3). 523–530. 126 indexed citations

20.

Lee, Sung Sook, Min Kyoung Kim, Sun Jin Sym, et al.. (2007). Intramedullary spinal cord metastases: a single-institution experience. Journal of Neuro-Oncology. 84(1). 85–89. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact